Invention Grant
- Patent Title: Compound composition for inhalation used for treating asthma
- Patent Title (中): 用于治疗哮喘的吸入化合物组合物
-
Application No.: US13876387Application Date: 2011-02-01
-
Publication No.: US08877740B2Publication Date: 2014-11-04
- Inventor: Wei-Hsiu Wu
- Applicant: Wei-Hsiu Wu
- Applicant Address: TW Taipei
- Assignee: Intech Biopharm Ltd.
- Current Assignee: Intech Biopharm Ltd.
- Current Assignee Address: TW Taipei
- Agency: Litron Patent & Trademark Office
- Agent Min-Lee Teng
- Priority: CN201010502339 20100928
- International Application: PCT/CN2011/070883 WO 20110201
- International Announcement: WO2012/041031 WO 20120405
- Main IPC: A01N45/00
- IPC: A01N45/00 ; A61K31/53 ; A61K31/573 ; A61K9/00 ; A61K31/135 ; A61K31/137 ; A61K31/4704 ; A61K31/56 ; A61K31/58 ; A61K31/138
Abstract:
A compound composition for inhalation comprising β2 receptor agonist and corticosteriod is provided in the present invention. The composition is used as a reliever for a patient with asthma or chronic obstructive pulmonary disease, or a controller in eccentric way, and can reduce drug acute resistance of β2 receptor agonist.
Public/Granted literature
- US20140031324A1 COMPOUND COMPOSITION FOR INHALATION USED FOR TREATING ASTHMA Public/Granted day:2014-01-30
Information query
